Batarda Sena Pedro Manuel, Rodrigues Joao, Das Neves Coelho Francisco, Soares Nunes Brenda, Fernandes Orlando, Fernandes Nicodemos, Nóbrega José J
Intensive Care Department, Hospital Central do Funchal, Funchal, PRT.
Helicopter Emergency Medical Service, Instituto Nacional de Emergência Médica, Lisbon, PRT.
Cureus. 2024 Aug 30;16(8):e68192. doi: 10.7759/cureus.68192. eCollection 2024 Aug.
Cardiac arrest is a common cause of death worldwide. Sodium bicarbonate (SB) has commonly been used during cardiopulmonary resuscitation (CPR) to correct metabolic acidosis (MA). However, the existence of evidence about its administration remains controversial. This systematic review aimed to summarize the effectiveness of SB in patients with in-hospital and out-of-hospital cardiac arrest. We searched Medline, Scopus, and the Cochrane Central Register of Controlled Trials (CENTRAL) for studies that used SB in cardiac arrest, from November 1962 until December 2023. A total of 372 records were identified and 12 studies were included. Despite few studies suggesting that SB may improve outcomes in prolonged CPR, the overall data revealed that SB was associated with lower rates of ROSC and outcomes. This review conceded that there is limited evidence to warrant the use of SB during CPR other than under specific conditions, which include hyperkalemic cardiac arrest, severe cardiotoxicity, or overdose due to tricyclic antidepressants. In conclusion, SB is not recommended for conventional use in patients with cardiac arrest. Further studies should be performed to determine whether it has any benefit in these scenarios.
心脏骤停是全球常见的死亡原因。碳酸氢钠(SB)在心肺复苏(CPR)期间常用于纠正代谢性酸中毒(MA)。然而,关于其使用的证据存在仍存在争议。本系统评价旨在总结SB对院内心脏骤停和院外心脏骤停患者的有效性。我们检索了Medline、Scopus和Cochrane对照试验中央注册库(CENTRAL),以查找1962年11月至2023年12月期间在心脏骤停中使用SB的研究。共识别出372条记录,纳入12项研究。尽管少数研究表明SB可能改善长时间心肺复苏的结果,但总体数据显示,SB与恢复自主循环(ROSC)率和预后较低相关。本评价承认,除了在特定情况下,包括高钾血症性心脏骤停、严重心脏毒性或三环类抗抑郁药过量,没有足够的证据支持在心肺复苏期间使用SB。总之,不建议在心脏骤停患者中常规使用SB。应进行进一步研究,以确定其在这些情况下是否有任何益处。